Detection of a novel immunoreactive endomorphin 2-like peptide in rat brain extracts

Regulatory Peptides

Volumn 148, Issue 1-3, 2008, Pages 54-61

  Szemenyei, Erzsébet ^a   Barna, István ^b   Mergl, Zsuzsa ^b   Keresztes, Attila ^a   Darula, Zsuzsanna ^a   Kató, Erzsébet ^c   Tóth, Géza ^a   Rónai, András Z ^c  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Gly5 endomorphins; Bioassays; Endomorphin; Novel endomorphin 2 immunoreactive species; Radioimmunoassay; Rat brain

Indexed keywords

ANTISERUM; BETA ENDORPHIN; BRAIN EXTRACT; CYPRODIME; DYNORPHIN; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KEYHOLE LIMPET HEMOCYANIN; MU OPIATE RECEPTOR AGONIST; NALOXONE; PARTIAL AGONIST; SULFUR 35;

ANIMAL TISSUE; ARTICLE; BIOASSAY; BIOSYNTHESIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE SYNTHESIS; VAS DEFERENS;

AMINO ACID SEQUENCE; ANIMALS; BETA-ENDORPHIN; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DYNORPHINS; ENKEPHALINS; IMMUNE SERA; MALE; MICE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PEPTIDES; RABBITS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 44349123333     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.03.001     Document Type: Article

References (37)

1. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective andogenous agonist for the μ-opiate receptor. Nature 386 (1997) 499-502
2. Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., and Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18 (1997) 1641-1649
3. Martin-Schild S., Gerall A.A., Kastin A.J., and Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405 (1999) 450-471
4. Pierce T.L., and Wessendorf M.W. Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat 18 (2000) 181-207
5. Greenwell T.G., Martin-Schild S., Inglis F.M., and Zadina J.E. Colocalization and shared distribution of endomorphins with substance P, calcitonin gene-related peptide,γ-aminobutyric acid, and the mu opioid receptor. J Comp Neurol 503 (2007) 319-333
6. Sánchez-Blázquez P., Rodriguez-Diaz M., DeAntonio I., and Garzón J. Endomorphin-1 and endomorphin-2 show differences in their activation of μ opioid receptor-regulated G protein sin supraspinal antinociception in mice. J Pharmacol Exp Ther 291 (1999) 12-18
7. Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol Ther 88 (2000) 437-463
8. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
9. Fichna J., Janecka A., Costentin J., and Do Rego J.C. The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59 (2007) 88-123
10. Wolfe D., Hao S., Hu J., Srinivasan R., Goss J., Mata M., Fink D.J., and Glorioso J.C. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain 133 (2007) 29-38
11. Terskiy A., Wannemacher K.M., Yadav P.N., Tsai M., Tian B., and Howells R.D. Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins. Life Sci 81 (2007) 1593-1601
12. Eipper B.A., Mains R.E., and Glembotski C.C. Identification in pituitary tissue of a peptide α -amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. Proc Natl Acad Sci USA 80 (1983) 5144-5148
13. Eipper B.A., and Mains R.E. Peptide α-amidation. Annu Rev Physiol 50 (1988) 333-344
14. 3H]-Tyr- Pro: A possible biosynthetic route for endomorphins. Reg Pept 134 (2006) 54-60
15. Al-Khrasani M., Orosz G., Kocsis L., Farkas V., Magyar A., Lengyel I., Benyhe S., Borsodi A., and Rónai A.Z. Receptor constants for endomorphin-1 and endomorphin 1-ol indicate differences in efficacy and receptor occupancy. Eur J Pharmacol 421 (2001) 61-67
16. Kocsis L., Benyhe S., Borsodi A., Rónai A.Z., and Magyar A Orosz G. Opioid related peptide alcohols: structure-activity studies. J Pept Sci S 197 (2000) 389
17. Tömböly C.S., Péter A., and Tóth G. In vitro quantitative study of the degradation of endomorphins. Peptides 23 (2002) 1573-1580
18. Tömböly C.s., Dixit R., Lengyel I., Borsodi A., and Tóth G. Preparation of specifically tritiated endomorphins. J Labelled Compd Radiopharm 44 (2001) 355-363
19. Goodfriend T.L., Levine L., and Fasman G.D. Antibodies to bradykinin and angiotensin: use of carbodiimides in immunology. Science 144 (1964) 1344-1346
20. Czernik A.J., and Petrack B. Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog. J Biol Chem 258 (1983) 5525-5530
21. Bozó B., Fülöp F., Tóth G.K., Tóth G., and Szu{double acute}cs M. Synthesis and opioid binding activity of dermorphin analogues containing cyclic β-amino acids. Neuropeptides 31 (1997) 367-372
22. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
23. Pasternak G.W., Wilson H.A., and Snyder S.H. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol Pharmacol 11 (1975) 340-351
24. Spetea M., Monory K., Tömböly C.s., Toth G., Tzavara E., Benyhe S., Hanoune J., and Borsodi A. In vitro binding and signalling profile of the novel μ-opioid receptor agonist endomorphin-2 in rat brain membranes. Biochem Biophys Res Commun 250 (1998) 720-725
25. Rónai A.Z., Gráf L., Székely J.I., and Dunai-Kovács Zs Bajusz S. Differential behaviour of LPH (61-91)-peptide in different model systems: comparison of the opioid activities of LPH(61-91)-peptide and its fragments. FEBS Lett 74 (1977) 182-184
26. Neubig R.R., Spedding M., Kenakin T., and Christopoulos A. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 55 (2003) 597-606
27. Kosterlitz H.W., and Watt A.J. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br J Pharmacol 33 (1968) 266-276
28. Schmidhammer H., Smith C.F., Erlach D., Koch M., Krassnig R., Schwetz W., and Wechner C. Synthesis and biological evaluation of 14-alkoxymorphinans. 3. Extensive study on cyprodime-related compounds. J Med Chem 33 (1990) 1200-1206
29. Portoghese P.S., Sultana M., and Takemori A.E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol 146 (1988) 185-186
30. Clapés P., Torres J.L., and Adlercreutz P. Enzymatic peptide synthesis in low water content systems: preparative enzymatic synthesis of [Leu]- and [Met]-enkephalin derivatives. Bioorg Med Chem 3 (1995) 245-255
31. Hänsler M., Ullmann G., and Jakubke H.D. The application of papain, ficin and clostripain in kinetically controlled peptide synthesis in frozen aqueous solutions. J Pept Sci 1 (1995) 283-287
32. Ye Y-H Tian G.L., Xing G.W., Dai D.C., Chen G., and Li C.X. Enzymatic syntheses of N-protected Leu-enkephalin and some oligopeptides in organic solvents. Tetrahedron 54 (1998) 12585-12596
33. Hackler L., Zadina J.E., Ge L.J., and Kastin A.J. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18 (1997) 1635-1639
34. Sun R.Q., Wang Y., Zhao C.S., Chang J.K., and Han J.S. Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain. Neurosci Lett 311 (2001) 13-16
35. Rónai A.Z., Al-Khrasani M., Benyhe S., Lengyel I., Kocsis L., Orosz G., Tóth G., Kató E., Fürst S., and Tóthfalusi L. Partial and full agonism in endomorphin derivatives: comparison by null and operational model. Peptides 27 (2006) 1507-1513
36. Bradbury A.F., Mistry J., Roos B.A., and Smyth D.G. 4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme). Eur J Biochem 189 (1990) 363-368
37. Driscoll W.J., Konig S., Fales H.M., Pannell L.K., Eipper B.A., and Mueller G.P. Peptidylglycine-alpha-hydroxylating monooxygenase generates two hydroxylated products from its mechanism-based suicide substrate, 4-phenyl-3-butenoic acid. Biochemistry 39 (2000) 8007-8016